Proposal of an improved prognostic classification for pT3 renal cell carcinoma

被引:20
|
作者
Terrone, C. [1 ]
Gontero, P. [4 ]
Volpe, A. [6 ]
Porpiglia, F. [6 ]
Bollito, E. [7 ]
Zattoni, F. [2 ]
Frea, B.
Tizzani, A. [4 ]
Fontana, D. [5 ]
Scarpa, R. M. [6 ]
Rossetti, S. Rocca [3 ]
机构
[1] Azienda Osped Maggiore Carita, Dept Urol, Novara, Italy
[2] Verona & Azienda Osped Santa Maria Misericordia, Dept Policlin GB Rossi, Udine, Italy
[3] Univ Turin, Turin, Italy
[4] Azienda Osped San Giovanni Battista, Dept Urol 1, Turin, Italy
[5] Azienda Osped San Giovanni Battista, Dept Urol 1, Turin, Italy
[6] Azienda Osped San Luigi Gonzaga, Dept Urol, Orbassano, Italy
[7] Azienda Osped San Luigi Gonzaga, Dept Pathol, Orbassano, Italy
来源
JOURNAL OF UROLOGY | 2008年 / 180卷 / 01期
关键词
kidney; prognosis; carcinoma; renal cell; nephrectomy; neoplasm staging;
D O I
10.1016/j.juro.2008.03.029
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The prognostic accuracy of the current, TNM 2002 staging system for locally advanced renal cell carcinoma has been questioned. To contribute to the development of a more accurate classification for this stage of disease we assessed the correlation between patterns of invasion in the pT3 category and outcomes in a large multi-institutional series. Materials and Methods: Pathological data and clinical followup on 513 pT3 renal cell carcinoma cases treated with radical nephrectomy between 1983 and 2005 at 3 Italian academic centers were retrospectively reviewed. Cause specific survival rates were calculated with the Kaplan-Meier method and multivariate analysis was performed using the Cox proportional hazards regression model. Results: Estimated overall 5-year cause specific survival was 50.1% at a median followup of 61.5 months in survivors. The current TNM classification was not a significant Outcome prognosticator. Patients with a tumor invading only the perirenal or sinus fat were at lowest risk for death from the disease. Patients at intermediate risk had tumors with invasion of the venous system alone. Simultaneous perirenal fat and sinus fat invasion or perirenal fat and vascular invasion as well as adrenal gland involvement characterized high risk tumors. Low risk tumors could be further divided into 2 groups with different outcomes based on a size cutoff of 7 cm. Our classification was a significant predictor of survival on multivariate analysis as well as M stage, N stage, Fuhrman grade and tumor size. Conclusions: We confirm that the prognostic usefulness of the current 2002 TNM system for pT3 renal cell carcinoma is limited. We have identified 4 groups of tumors with distinct patterns of invasion and significantly different survival probabilities in this category. Large prospective series are needed to validate these findings.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 50 条
  • [41] The 2003 pN classification for renal cell carcinoma: Can its prognostic accuracy be improved?
    Dimashkieh, H
    Lohse, CM
    Leibovich, B
    Kwon, ED
    Blute, ML
    Cheville, JC
    [J]. MODERN PATHOLOGY, 2005, 18 : 137A - 137A
  • [42] The 2003 pN classification for renal cell carcinoma: Can its prognostic accuracy be improved?
    Dimashkieh, HH
    Lohse, CM
    Leibovich, BC
    Kwon, E
    Blute, ML
    Cheville, JC
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 137A - 137A
  • [43] Prognostic significance of the site of invasion in pT3a renal cell carcinoma
    Lee, H. Y.
    Nam, K. H.
    Kim, D.
    Park, J. J.
    Kim, D.
    Suh, J.
    Kang, M.
    Seo, S., I
    Jeong, C. W.
    Kwak, C.
    Song, C.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S2163 - S2163
  • [44] International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis
    Roscigno, Marco
    Cha, Eugene K.
    Rink, Michael
    Seitz, Christian
    Novara, Giacomo
    Chromecki, Thomas F.
    Fritsche, Hans-Martin
    Matsumoto, Kazumasa
    Walton, Thomas J.
    Carballido, Joaquin
    Da Pozzo, Luigi Filippo
    Bertini, Roberto
    Ficarra, Vincenzo
    Otto, Wolfgang
    Karakiewicz, Pierre I.
    Pycha, Armin
    Fajkovic, Harun
    Naspro, Richard
    Scherr, Douglas S.
    Montorsi, Francesco
    Shariat, Shahrokh F.
    [J]. BJU INTERNATIONAL, 2012, 110 (05) : 674 - 681
  • [45] PROGNOSTIC SIGNIFICANCE OF THE SITE OF INVASION IN PT3A RENAL CELL CARCINOMA
    Lee, Hyun Young
    Kang, Homin
    Cho, Jaeyoung
    Suh, Jungyo
    Kang, Minyong
    Seo, Seong Il
    Jeong, Chang Wook
    Kwak, Cheol
    Song, Cheryn
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E142 - E142
  • [46] The impact of selected surgical approach on postoperative morbidity in the management of advanced renal cell carcinoma (pT3, pT4)
    Sachova, J.
    Palascak, P.
    Urban, M.
    Gomez-Orozco, W.
    Sauvain, J. L.
    Nader, N.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 676 - 676
  • [47] Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification
    Shariat, Shahrokh F.
    Zigeuner, Richard
    Rink, Michael
    Margulis, Vitaly
    Hansen, Jens
    Kikuchi, Eiji
    Kassouf, Wassim
    Raman, Jay D.
    Remzi, Mesut
    Koppie, Theresa M.
    Bensalah, Karim
    Guo, Charles C.
    Mikami, Shuji
    Sircar, Kanishka
    Ng, Casey K.
    Haitel, Andrea
    Kabbani, Wareef
    Chun, Felix K.
    Wood, Christopher G.
    Scherr, Douglas S.
    Karakiewicz, Pierre I.
    Langner, Cord
    [J]. EUROPEAN UROLOGY, 2012, 62 (02) : 224 - 231
  • [49] Locally advanced (pT3-pT4) renal cell carcinoma: Comparison of different PT proposal of reclassification
    Bertini, R.
    Roscigno, M.
    Briganti, A.
    Gallina, A.
    Pasta, A.
    Strada, E.
    Petralia, G.
    Da Pozzo, L. F.
    Bocciardi, A.
    Rigatti, P.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 160 - 160
  • [50] PT3 SUBSTAGING IS A PROGNOSTIC INDICATOR IN LYMPH NODE NEGATIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Tilki, D.
    Novara, G.
    Ficarra, V
    Seitz, M.
    Kassouf, W.
    Fradet, Y.
    Skinner, E.
    Stief, C. G.
    Reich, O.
    Shariat, S. F.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 99 - 99